(Q33395870)

26 July 2017

title

Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report (English)

1 reference

26 July 2017

0 references

kidney transplantation

1 reference

S Chandran

1

1 reference

26 July 2017

L Baxter-Lowe

2

1 reference

26 July 2017

J L Olson

3

1 reference

26 July 2017

S J Tomlanovich

4

1 reference

26 July 2017

A Webber

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

Transplantation Proceedings

26 July 2017

published in

1 reference

26 July 2017

volume

43

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

2097-2101

1 reference

Thrombotic microangiopathy after kidney transplantation

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Thrombotic Microangiopathy After Kidney Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Intravenous immunoglobulin a natural regulator of immunity and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Therapeutic potential of complement modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Outcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

From humoral rejection to generalized thrombotic microangiopathy--role of acquired ADAMTS13 deficiency in a renal allograft recipient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.02.064

10.1016/J.TRANSPROCEED.2011.02.064

7 January 2021

Identifiers

DOI

1 reference

release_r2vs7sgzi5erjafx4pdp2a274u

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r2vs7sgzi5erjafx4pdp2a274u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference